Parse Biosciences launches a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker.

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

Elanco Animal Health Incorporated will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the ...

Caris and Everlywell are partnering to launch Caris Detect™, Caris' forthcoming Multi-Cancer Early Detection (MCED) ...

CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Melanoma, known for its aggressiveness and high mutational burden, presents itself as a prime candidate for neoantigen-targeted immunotherapies. Although ...

Caris Life Sciences plans to report its complete fourth quarter and full year 2025 financial results during its earnings call ...

Parse Biosciences & Graph Therapeutics partner to build large functional immune perturbation atlas: Seattle Thursday, January 22, 2026, 11:00 Hrs [IST] Parse Biosciences, a global ...

A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how the disease progresses and patient outcomes. These "tissue-resident" microbes ...